✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Shanghai Junshi Biosciences Co Ltd

Common Name
Shanghai Junshi Biosciences
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
2,578
Ticker
688180
Exchange
SHANGHAI STOCK EXCHANGE
Description
Shanghai Junshi Biosciences Co., Ltd. is a prominent biopharmaceutical company based in China, engaged in the research, development, and commercialization of innovative therapeutics for a range of dis...

Shanghai Junshi Biosciences's GHG Emissions Data Preview

In 2024, Shanghai Junshi Biosciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Shanghai Junshi Biosciences has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)202420232022
2021 - 2017
Total Scope 1
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy/Paste is a PRO feature.
a
0000000
Copy/Paste is a PRO feature.
b
0000000
Total Scope 3
Copy/Paste is a PRO feature.
Copy/Paste is a PRO feature.
0000000
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
0000000
Copy/Paste is a PRO feature.
b
Copy/Paste is a PRO feature.
b
0000000
Limited Data Preview
You are viewing a limited preview of Shanghai Junshi Biosciences’s GHG emissions dataset. The full dataset, available for download, includes Scope 1, 2, and 3 emissions with detailed category-level breakdowns, historical coverage back to 2019, and revenue-based intensity metrics for each scope.
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=688180&reporting_period=2024"

Verified Sources Behind Shanghai Junshi Biosciences’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Shanghai Junshi Biosciences’s data sources below and access millions more through our Disclosure Search.

a. Shanghai Junshi Biosciences's ESG Report 2024
b. Shanghai Junshi Biosciences's Annual Report 2023

Insights into Shanghai Junshi Biosciences's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Shanghai Junshi Biosciences amounted to 26,800.75 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Shanghai Junshi Biosciences decreased by 22.48%, showing that the company has made progress in taking action to reduce the climate impact of its operations.ab

Shanghai Junshi Biosciences's Scope 1 Emissions Over Time

20192020202120222023202402.5 k5 k7.5 k10 ktCO2e+52%+40%+10%-17%-28%
  • Total Scope 1
  • Year-over-Year Change

What are Shanghai Junshi Biosciences's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Shanghai Junshi Biosciences were 5,307.75 metric tons of CO₂ equivalent (tCO₂e).a

Has Shanghai Junshi Biosciences reduced its Scope 1 emissions over time?

Since 2019, Shanghai Junshi Biosciences's Scope 1 emissions have increased by 39.21%, reflecting a rising long-term trend in Scope 1 emissions over time.ab

Compared to the previous year (2023), Shanghai Junshi Biosciences's Scope 1 emissions decreased by 27.58%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.ab

What are Shanghai Junshi Biosciences's Scope 2 emissions?

In 2024, Shanghai Junshi Biosciences reported Scope 2 greenhouse gas (GHG) emissions of 21,493 tCO₂e without specifying the calculation method.a

Has Shanghai Junshi Biosciences reduced its Scope 2 emissions over time?

Since 2019, Shanghai Junshi Biosciences's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 65.23%, reflecting a rising long-term trend in Scope 2 emissions over time.ab

Compared to the previous year (2023), Shanghai Junshi Biosciences's Scope 2 emissions (Unspecified Calculation Method) fell by 21.11% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.ab

What methodology does Shanghai Junshi Biosciences use for Scope 2 reporting?

In 2024, Shanghai Junshi Biosciences reported its Scope 2 emissions using an unspecified methodology.a

Shanghai Junshi Biosciences's Scope 2 Emissions Over Time

20192020202120222023202407.5 k15 k22.5 k30 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Shanghai Junshi Biosciences’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Shanghai Junshi Biosciences reported Scope 1 greenhouse gas (GHG) emissions of 5,307.75 tCO₂e and total revenues of USD 267 millions. This translates into an emissions intensity of 19.88 tCO₂e per millions USD.a

Shanghai Junshi Biosciences's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202001,00010,000Revenues (Millions of USD)AASDInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 106Scope 1 Intensity: 0.00 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,409Scope 1 Intensity: 0.03 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MDDDaShenLin Pharmaceutical GroupYear: 2024Scope 1: 5,220 tCO2eRevenue: $M 3,631Scope 1 Intensity: 1.44 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,779Scope 1 Intensity: 13.80 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$M

How does Shanghai Junshi Biosciences's GHG emissions intensity compare to its peers?

In 2024, Shanghai Junshi Biosciences reported a Scope 1 emissions intensity of 19.88 tCO₂e per millions USD. Compared to the peer group median of 8.32, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Shanghai Junshi Biosciences rank on GHG emissions intensity within its industry?

In 2024, Shanghai Junshi Biosciences ranked 17 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a

Shanghai Junshi Biosciences is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a

Want Full Access to Shanghai Junshi Biosciences's GHG Emissions Dataset?
Start 30-Day Free Trial